As previously observed, tumor volume was significantly reduced in response to NVB in mice bearing KPC Brca2 KO cells; however, the antitumor efficacy of NVB was significantly impaired in STING-depleted tumors (Fig. 8g; Supplementary Fig. 7c). The gene discussed is STING1; the disease is neoplasm.